Remove tag regulatory-frameworks
article thumbnail

What is modular content and why do pharma marketers need it NOW?

pharmaphorum

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. It might encompass elements such as headlines, body copy, images, calls-to-action, legal copy and logos, and the content can then be used as a framework for messages. A modular content ecosystem.

Marketing 102
article thumbnail

New Rare Disease Drugs and Research Advancements

XTalks

Despite high price tags of a couple of million dollars, gene therapy makers say they are working to ensure patients are able to access the treatments through patient assistance programs developed in conjunction with the support of governments. Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

The beauty about the framework is that once it is optimized, all you have do is change out the peptide and you change the target indication, explains Dr. Suri. The core framework of the Immuno-STAT molecule consists of: HLA peptide – specifically HLA-A*02, which is the most dominant HLA allele in North America and Western Europe.

Protein 98
article thumbnail

Salesforce Platform Capabilities

Cloudbyz

Apex and Visualforce: For more advanced customizations, you can use Apex, Salesforce’s proprietary programming language, and Visualforce, a framework for building custom user interfaces. It offers additional levels of transparency, compliance, and governance to help organizations meet their complex regulatory requirements.

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

The presentations are as follows: Fabian Schmich, PhD, Senior Data Scientist, pRED Informatics, Roche Diagnostics Deutschland, on: ‘scifAI: An explainable machine learning framework applied to functional characterisation of therapeutic antibodies’.

Protein 59
article thumbnail

Grand Rounds June 9, 2023: Emulating Randomized Clinical Trials with Non-randomized Real-world Evidence Studies: Results From The RCT DUPLICATE Initiative (Shirley V. Wang, PhD)

Rethinking Clinical Trials

How do we teach our students and colleagues how to use the target trial framework and use these emulation approaches to advance our comparative effectiveness studies? The first aim of the project is to use healthcare databases to emulate the design of 30 completed trials and predict the results of 7 ongoing trials.